In patients with an indication for oral anticoagulation undergoing coronary stenting, in-hospital major bleeding is clinically relevant (4.3%) and should be accounted for when evaluating overall hemorrhagic risk.
No takes yet. Share an insight, caveat, or question.
Major bleeding warrants attention in anticoagulated stenting patients; observational data leaves open femoral access as a modifiable bleeding risk factor.
Rubboli et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: